Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Assembly Biosciences

NASDAQ ASMB
$13.40 0.39 2.91%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 29 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

73.48M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
54.86M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.40
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
5.48M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
1,533.95 %

Upcoming events Assembly Biosciences

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Assembly Biosciences

Stock analysis Assembly Biosciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-1.43 16.17
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
1.79 4.32
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.99 8.89
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.34 0.64
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-157.53 4.05

Price change Assembly Biosciences per year

3.09$ 16.62$
Min Max

Summary analysis Assembly Biosciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Assembly Biosciences

Revenue and net income Assembly Biosciences

All parameters

Stock news Assembly Biosciences

All news
17 October 2023 в 15:16

Assembly Biosciences Shares Soar Premarket on Gilead Pact

17 October 2023 в 15:16

Assembly Biosciences Shares Soar Premarket on Gilead Pact

5 October 2022 в 23:25

Assembly Biosciences CEO John McHutchison to Retire, Succeeded by Jason Okazaki

5 October 2022 в 23:20

Assembly Biosciences CEO John McHutchison to Retire, Succeeded by Jason Okazaki

1 April 2022 в 14:15

Assembly Biosciences stock price target cut to $12 from $15 at Truist

2 September 2021 в 17:55

Assembly Biosciences Shares Drop After Discontinuing Development of a Treatment

2 September 2021 в 17:55

Assembly Biosciences Shares Drop After Discontinuing Development of a Treatment

About company Assembly Biosciences

Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H2158, which is in Phase II clinical study for chronic HBV infection; ABI-H3733 that has completed Phase Ia clinical study for the treatment of HBV. The company has collaboration agreements with Allergan Pharmaceuticals International Limited; BeiGene, Ltd.; and Arbutus Biopharma Corporation, as well as strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. It also has a clinical collaboration agreement with Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California.
Address:
331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Company name: Assembly Biosciences
Issuer ticker: ASMB
ISIN: US0453961080
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2010-12-17
Sector: Healthcare
Industry: Biotechnology
Site: https://www.assemblybio.com

On which stock exchange are Assembly Biosciences (ASMB) stocks traded?

Assembly Biosciences (ASMB) stocks are traded on NASDAQ.

What is the ticker of Assembly Biosciences stocks (ASMB)?

The stock ticker of Assembly Biosciences’s stocks or in other words, the code is ASMB. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Assembly Biosciences (ASMB) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Assembly Biosciences (ASMB) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Assembly Biosciences (ASMB) stocks traded?

Assembly Biosciences (ASMB) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Assembly Biosciences (ASMB) stocks today?

The current price of Assembly Biosciences stocks on 13.05.2024 is 13.4 dollars. per share.

What is the dynamics of Assembly Biosciences (ASMB) stocks from the beginning of the year?

Assembly Biosciences (ASMB) quotes have increased by 1510.58% from the beginning of the year up to 13.4 dollars. per 1 stocks.

How much did Assembly Biosciences (ASMB) stocks increase in мае 2024?

This month Assembly Biosciences (ASMB) quotes have increased by 0.98% to 13.4 dollars. per share.

How much are Assembly Biosciences (ASMB) stocks worth?

Today, on October, 13.05.2024 Assembly Biosciences’s (ASMB) stocks cost 13.4 dollars..

What is the market capitalization of Assembly Biosciences (ASMB)?

Capitalization is the market value of Assembly Biosciences (ASMB) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 13.05.2024, the market capitalization of Assembly Biosciences (ASMB) is estimated at about 73476394 dollars.